HHS-2025-ACL-AOA-ADPI-0027: Alzheimer's Disease Programs Initiative - Dementia Capability in Indian Country
Closed
This grant is closed. A newer notice from the same program is forecast: Alzheimer's Disease Programs Initiative (ADPI) - Dementia Capability in Indian Country (HHS-2027-ACL-AOA-ADPI-0010). Status: Expected deadline May 3, 2027. It is in our archive of Administration for Community Living notices from 2025.
Administration for Community Living offered grants of up to $300,000 (at least $200,000) to tribes. It expected to make about 7 awards worth $2.0 million in total. Applications closed on August 25, 2025.
From the official notice on Grants.gov, last changed July 25, 2025. Checked November 7, 2026.
- Award ceiling$300,000
- Award floor$200,000
- Total funding$2.0 million
- Expected awards7
- Cost sharingRequired
- Funding typeCooperative Agreement
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| HHS-2021-ACL-AOA-ADPI-0104 | May 17, 2021 | Closed July 19, 2021 | Closed |
Key dates
| Posted | July 25, 2025 |
|---|---|
| Deadline | August 25, 2025 |
| Archived by Grants.gov | August 1, 2029 |
Who can apply
This opportunity was open to tribes.
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
Applicants for the Dementia Capability in Indian Country cooperative agreement are those entities that are presently responsible for the provision of and actively providing home and community-based services in tribal communities (i.e. tribes, tribal organizations and/or consortiums representing federally recognized tribes). Foreign entities are not eligible to compete for, or receive, awards made under this announcement.
Is this a realistic fit?
- Past Alzheimer’s Disease Program Initiative (ADPI) awards averaged $937,408; this notice allows up to $300,000 per award.
- Most of the program's money (81% over five years) went to nonprofits.
- The notice requires cost sharing or matching funds, so you must contribute part of the project cost.
What the grant funds
Cooperative agreements under this Alzheimer"s Disease Programs Initiative (ADPI) funding opportunity announcement (FOA) are intended to support and promote the development and implementation of dementia-capable home and community-based service (HCBS) systems in Indian Country. The Dementia Capability in Indian Country program is intended to support federally recognized tribes, tribal organizations and/or consortiums representing federally recognized tribes in these target activities. The dementia-capable systems resulting from activities under this program are expected to provide quality, strengths-based, person-centered services and supports that help people living with dementia and their caregivers remain independent and safe in their communities. There are two application options contained in this single NOFO: Option A: Grants to Tribes and Tribal Entities that have previously received ADPI grants, and Option B: Grants to Tribes and Tribal Entities that are new to the ADPI program. Applicants for the 36-month Dementia Capability in Indian Country cooperative agreement are those entities that are presently responsible for the provision of and actively providing home and community-based services in tribal communities (i.e. tribes, tribal organizations and/or consortiums representing federally recognized tribes). Applicants for Option A will propose the ways in which they will expand on their previously funded ADPI programs and applicants under Option B will propose to enhance existing service systems with dementia services, resulting in the provision of services to Tribal Elders and their caregivers through a dementia-capable system. Responsive applications will demonstrate tribal leadership support and the authority to conduct the activities proposed in their application.
Who has won Alzheimer’s Disease Program Initiative (ADPI) grants before
From fiscal 2021 to 2025, Alzheimer’s Disease Program Initiative (ADPI) (93.470) awarded $74.1 million across 79 grant awards, an average of $937,408 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Alzheimers Disease & Related Disorders Association Inc | Illinois | 3 | $13.3 million |
| Alzheimer's Greater Los Angeles | California | 2 | $2.0 million |
| Oakwood Creative Care Inc | Arizona | 2 | $2.0 million |
| Carelink, Inc. | Rhode Island | 2 | $1.9 million |
| North Central Texas Council of Governments | Texas | 2 | $1.8 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HHS-2027-ACL-AOA-ADPI-0010, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HHS-2025-ACL-AOA-ADPI-0027 still open?
No. It closed on August 25, 2025. A newer notice is forecast: HHS-2027-ACL-AOA-ADPI-0010, expected deadline May 3, 2027.
Who can apply for Alzheimer's Disease Programs Initiative - Dementia Capability in Indian Country?
Administration for Community Living accepted applications from tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Alzheimer's Disease Programs Initiative - Dementia Capability in Indian Country?
Closed August 25, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $300,000 each. About $2.0 million in total across about 7 awards.
Who has won Alzheimer’s Disease Program Initiative (ADPI) grants before?
The largest recipients over five fiscal years were Alzheimers Disease & Related Disorders Association Inc, Alzheimer's Greater Los Angeles, Oakwood Creative Care Inc. The program made 79 awards worth $74.1 million in that time.
Similar open grants
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Head Start/Early Head Grants in Multiple States